Baseline levels of serum TNF-α have been associated with treatment response in IBD and provide a good estimation of global disease burden and need for medication escalation in other chronic conditions, such as rheumatoid arthritis37–39. The gene discussed is TNF; the disease is inflammatory bowel disease.